PLOD2 and neoplasm: To determine whether LH2 influences intra-tumoral immunity, we quantified immune cell subsets in subcutaneous tumors generated by Plod2 KO or parental 344SQ cells and identified alterations in T cell and myeloid cell subsets that were consistent with an anti-tumor response in Plod2 KO tumors (Fig. 1g, h).